About The Course
Gain the knowledge and skills to confidently address ADHD in Childhood and Adolescence. This course covers the latest evidence on ADHD diagnosis and treatment, including assessment strategies, pharmacological and non-pharmacological interventions, and managing complex presentations. Through interactive case studies, you’ll apply guidelines to real-world scenarios, enhancing your ability to deliver effective, patient-centred care for children and adolescents with ADHD.
Who Is This Course For?
This course is suitable for:
- Psychiatrists
- General Practitioners (GPs)
- Mental Health Nurse Practitioners (MHNPs)
- Psychologists
- Mental health professionals
- Clinicians working in or expanding into psychiatry and mental health care
Accreditation Information:
- Psychiatry Accreditation: This course is available for self-accreditation with the RANZCP and other relevant psychiatric and mental health organisations.
- GP Accreditation: The course is RACGP and ACRRM accredited for general practitioners.
What You'll Learn
- Discuss the epidemiology of ADHD in Children and Adolescents
- Explore the psychosocial and educational impacts of ADHD
- Support clinicians in the evidence-based assessment and diagnosis of ADHD in children and adolescents through the use of the latest clinical guidelines
- Recognise the latest pharmacological and non-pharmacological strategies to treat and manage ADHD
- Consolidate knowledge through an interactive case study and a final knowledge test
Course Programme
7 Units | 18 Modules | 4.5 hours total length
- The Psychosocial and Educational Impacts of ADHD
- Key predictors of Outcomes
- Brain changes in ADHD
- Diagnosing ADHD
- Assessment Strategies
- Ruling In/Out Comorbidities
- Psychiatric Comorbidities
- Management Principles for ADHD
- Pharmacological and Non-pharmacological Treatment Strategies for ADHD
- Reasons for Choosing Different Treatment Approaches
- Pharmacological Treatment of ADHD in Children and Adolescents
- Before Initiating Pharmacotherapy
- Efficacy and Functional Benefits
- Available First Line Medications, Second Line Drug Treatments
- Prescribing in Special Populations
- Medication Choice and Formulation
- Pharmaceutical Benefits Scheme (PBS) and Repatriation Pharmaceutical Benefits Scheme (RPBS) Prescriptions Requirements, Specific Rules
- Prescriptions Requirements for Schedule 8 Drugs
- Diagnosing Childhood ADHD: Application Through Two Case Studies
- Knowledge check
Course Description
Diagnosis and Management of ADHD in Childhood and Adolescence: A Clinical Guide for Practitioners
ADHD in Childhood and Adolescence is one of the most prevalent neurodevelopmental disorders, with impacts across learning, behaviour, and family life. For clinicians, its complexity lies not only in recognition but also in the careful balance of comorbidities, treatment options, and long-term planning. This course translates the latest guidelines into clear, practical steps for assessment, intervention, and collaboration.
Delivered over seven units and eighteen modules, the program combines clinical evidence with interactive activities, case studies, and infographics. It equips professionals with the skills needed for Managing ADHD in young people and applying evidence-based strategies for ADHD diagnosis and treatment.
Units 1–2: Epidemiology, Impacts, and Neurobiology
The opening units explore prevalence, ADHD subtypes, and key predictors of outcomes. Participants examine psychosocial and educational challenges, including academic performance, suspension risks, and comorbidities. Neurobiological insights highlight structural and functional brain changes, grounding clinical understanding of ADHD in Childhood and Adolescence.
Units 3–4: Assessment and Treatment Pathways
These units present a structured approach to assessment, aligned with DSM-5 and NHMRC guidelines. Clinicians are guided through developmental history, rating scales, red flags, and the diagnostic hierarchy, with an emphasis on recognising comorbidities and ruling out medical causes.
Management principles are then introduced, spanning lifestyle and behavioural strategies through to pharmacological care. Stimulant medications are covered as first-line treatments, with non-stimulants outlined as second-line options. Practical modules focus on titration, monitoring, side-effect management, and enhancing adherence. PBS, RPBS, and Schedule 8 prescribing requirements are also clarified, ensuring participants can confidently navigate ADHD diagnosis and treatment in practice.
Units 5–7: Case Studies and Long-Term Management
Theory is consolidated through two interactive case studies. Jenny, an eight-year-old with ADHD and anxiety, illustrates diagnostic reasoning and staged treatment planning. Alex, a teenager with ADHD and substance use, highlights dual diagnosis, adherence difficulties, risk, and ethical dilemmas.
Participants then explore transitions to adulthood, school engagement, and long-term strategies. A knowledge check reinforces best-practice approaches for Managing ADHD in young people across diverse clinical settings.
Learning Objectives
By the end of the course, participants will be able to:
- Apply epidemiology and developmental data to clinical decision-making.
- Conduct structured assessments using history, rating scales, and red-flag indicators.
- Differentiate ADHD from overlapping disorders and identify co-occurring conditions.
- Select and sequence lifestyle, behavioural, and pharmacological interventions.
- Titrate and monitor medicines, manage side effects, and support adherence.
- Navigate PBS, RPBS, and Schedule 8 prescribing requirements.
- Formulate management strategies for dual diagnosis, risk, and transitions to adulthood.
This course integrates foundations, treatment strategies, and applied case learning into a single program. By its conclusion, participants will be equipped to deliver confident, guideline-aligned care for ADHD in Childhood and Adolescence, strengthening their expertise in both ADHD diagnosis and treatment and Managing ADHD in young people.
Enrol today to sharpen your clinical skills and improve outcomes for children and adolescents living with ADHD. Upon completion of this course, participants will receive 4.5 CPD (EA-2.5, MO-1, RP-1) hours and a course completion certificate.
Related Courses
- Adult ADHD Clinical Training Program | 7-Course Series for Psychiatrists & GPs: This comprehensive curriculum brings together ADHD training across the lifespan, covering neurobiology, assessment, differential diagnosis, psychopharmacology and clinical management. It provides an integrated approach to understanding ADHD from childhood through to adulthood.
- Understanding Autism Spectrum Disorder: A Comprehensive Guide to Clinical Assessment & Diagnosis: Given the diagnostic overlap and co-occurrence of ADHD and autism, this course strengthens developmental history-taking, clinical assessment and differential diagnosis. It supports clinicians in recognising complex neurodevelopmental presentations and identifying co-occurring conditions.
- Gaming Addiction and Mental Health: Particularly relevant to clinicians working with children and adolescents, this course explores the assessment and management of gaming disorder, including its relationship with ADHD and autism. It examines psychological interventions, parenting strategies and family support in managing problematic gaming behaviours.
- Sleep and Psychiatry: Neuropsychiatric and Precision Approaches: Sleep disturbances can complicate ADHD assessment and management. This course explores sleep–wake regulation, sleep disorders and evidence-based treatment approaches, providing a broader clinical framework for understanding sleep-related difficulties in psychiatric presentations.
This course delivers evidence-based strategies for managing ADHD in young people, combining diagnosis, treatment approaches, and case studies to strengthen clinical decision-making and improve patient care.




